Advanced search
Publication Cover
Leukemia & Lymphoma Volume 62, 2021 - Issue 3
Submit an article Journal homepage
1,954
Views
32
CrossRef citations to date
0
Altmetric
Original Articles

Blinatumomab + ponatinib for relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia in adults

Marie-Anne Couturiera Department of Hematology, Hôpital Morvan, CHRU Brest, Brest, FranceCorrespondence[email protected]
,
Xavier Thomasb Department of Hematology, Hôpital Lyon-Sud, Lyon, France
,
Emmanuel Raffouxc Department of hematology, APHP St-Louis, Paris, France
,
Françoise Huguetd Department of Hematology, CHRU – Institut Universitaire de Cancer Toulouse – Oncopole, Toulouse, France
,
Céline Berthone Department of Hematology, Hôpital Claude Huriez, CHRU Lille, Lille cedex, France
,
Célestine Simandf Department of Hematology, CHU de Hautepierre, Strasbourg, France
,
Maria-Pilar Gallego-Hernanzg Department of Hematology, CHU La Miletrie, Poitiers, France
,
Yosr Hicherih Department of Hematology, Hôpital Saint Eloi, CHRU Montpellier, Montpellier, France
,
Mathilde Hunault Bergeri Department of Hematology, CHRU Angers, Angers, France
,
Colombe Saillardj Department of Hematology, Institut Paoli Calmettes, Marseille, France
,
Thibaut Leguayk Department of Hematology, Hôpital Haut-Leveque, CHU Bordeaux, Bordeaux, France
,
Clémence Loiseaul Department of Hematology Oncology, CH de Versailles, Hôpital André Mignot, Le Chesnay, France
,
Marie-Christine Béném Department of Hematology/Biology, CHU Nantes, Nantes, France
&
Patrice Chevalliern Department of Hematology, CHU Nantes, Nantes, France
 show all
Pages 620-629 | Received 15 Jun 2020, Accepted 23 Oct 2020, Published online: 06 Nov 2020

Citations (32)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Franco Locatelli, Bijal Shah, Tracy Thomas, Kelly Velasco, Babatunde Adedokun, Ibrahim Aldoss, Lia Gore, Dieter Hoelzer, Renato Bassan, Jae H. Park, Nicolas Boissel & Hagop Kantarjian. (2023) Incidence of CD19-negative relapse after CD19-targeted immunotherapy in R/R BCP acute lymphoblastic leukemia: a review. Leukemia & Lymphoma 0:0, pages 1-19.
Read now
Zheng Shi, Yiqian Zhu, Jing Zhang & Baoan Chen. (2022) Monoclonal antibodies: new chance in the management of B-cell acute lymphoblastic leukemia. Hematology 27:1, pages 642-652.
Read now
Jay Yang, Malini Surapaneni & Charles A. Schiffer. (2022) An evaluation of ponatinib as a therapy in adult patients with resistant/intolerant chronic-phase chronic myeloid leukemia. Expert Review of Hematology 15:5, pages 393-402.
Read now
Michela Ansuinelli, Laura Cesini, Sabina Chiaretti & Robin Foà. (2021) Emerging tyrosine kinase inhibitors for the treatment of adult acute lymphoblastic leukemia. Expert Opinion on Emerging Drugs 26:3, pages 281-294.
Read now
Katsuhiro Miura, Noriyoshi Iriyama, Yoshihiro Hatta & Masami Takei. (2021) Personalized patient care with aggressive hematological malignancies in non-responders to first-line treatment. Expert Review of Precision Medicine and Drug Development 6:3, pages 203-215.
Read now

Articles from other publishers (27)

Jianghua Ding & Wen Li. (2023) Case report: Olverembatinib monotherapy: the chemotherapy-free regimen for an elderly patient with relapsed Ph-positive acute lymphoblastic leukemia. Frontiers in Pharmacology 14.
Crossref
Kseniia S. Afanaseva, Evgeny A. Bakin, Anna G. Smirnova, Ildar M. Barkhatov, Tatiana L. Gindina, Ivan S. Moiseev & Sergey N. Bondarenko. (2023) A pilot study of implication of machine learning for relapse prediction after allogeneic stem cell transplantation in adults with Ph-positive acute lymphoblastic leukemia. Scientific Reports 13:1.
Crossref
Josep-Maria Ribera, Thibaud Prawitz, Andreas Freitag, Anuj Sharma, Balázs Dobi, Federica Rizzo, Lorenzo Sabatelli & Petros Patos. (2023) Ponatinib vs. Imatinib as Frontline Treatment for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Matching Adjusted Indirect Comparison. Advances in Therapy 40:7, pages 3087-3103.
Crossref
Matteo Di Nardo, Graeme MacLaren, Peter Schellongowski, Elie Azoulay, Amy E DeZern, Cristina Gutierrez, Massimo Antonelli, Marta V Antonini, Gernot Beutel, Alain Combes, Rodrigo Diaz, Ibrahim Fawzy Hassan, Jo-Anne Fowles, In-Seok Jeong, Matthias Kochanek, Tobias Liebregts, Catherina Lueck, Karen Moody, Jessica A Moore, Laveena Munshi, Matthew Paden, Frédéric Pène, Kathryn Puxty, Matthieu Schmidt, Dawid Staudacher, Thomas Staudinger, Joachim Stemmler, R Scott Stephens, Lisa Vande Vusse, Philipp Wohlfarth, Roberto Lorusso, Antonio Amodeo, Kris M Mahadeo & Daniel Brodie. (2023) Extracorporeal membrane oxygenation in adults receiving haematopoietic cell transplantation: an international expert statement. The Lancet Respiratory Medicine 11:5, pages 477-492.
Crossref
Anjali S. Advani, Anna Moseley, Kristen M. O’Dwyer, Brent L. Wood, Jae Park, Matthew Wieduwilt, Deepa Jeyakumar, George Yaghmour, Ehab L. Atallah, Aaron T. Gerds, Susan M. O'Brien, Jane L. Liesveld, Megan Othus, Mark Litzow, Richard M. Stone, Elad Sharon & Harry P. Erba. (2023) Dasatinib/prednisone induction followed by blinatumomab/dasatinib in Ph+ acute lymphoblastic leukemia. Blood Advances 7:7, pages 1279-1285.
Crossref
Heng Liu, Rui Xi, Dongfeng Mao, Xiaochen Zhao & Tao Wu. (2023) Efficacy and Safety of Blinatumomab for the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia: A Systemic Review and Meta-Analysis. Clinical Lymphoma Myeloma and Leukemia 23:3, pages e139-e149.
Crossref
Fadi G. Haddad, Jacki Sawyers & Nicholas J. Short. (2023) Treatment de-escalation in Philadelphia chromosome–positive B-cell acute lymphoblastic leukemia: the emerging role of chemotherapy-free regimens. Therapeutic Advances in Hematology 14, pages 204062072311512.
Crossref
Sarju Ganatra, Sourbha S. Dani, Eric H. Yang, Vlad G. Zaha & Anju Nohria. (2022) Cardiotoxicity of T-Cell Antineoplastic Therapies. JACC: CardioOncology 4:5, pages 616-623.
Crossref
Fadi G. Haddad, Hagop Kantarjian & Elias Jabbour. (2022) EXABS-133-ALL Approach to Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia. Clinical Lymphoma Myeloma and Leukemia 22, pages S39-S41.
Crossref
Josep-Maria Ribera & Sabina Chiaretti. (2022) Modern Management Options for Ph+ ALL. Cancers 14:19, pages 4554.
Crossref
Elias Jabbour, Fadi G. Haddad, Nicholas J. Short & Hagop Kantarjian. (2022) Treatment of Adults With Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia—From Intensive Chemotherapy Combinations to Chemotherapy-Free Regimens. JAMA Oncology 8:9, pages 1340.
Crossref
Guru Subramanian Guru Murthy & Ehab Atallah. (2022) Relapsed/Refractory Acute Lymphoblastic Leukemia in Adults: Progress and Challenges. JCO Oncology Practice 18:7, pages 489-490.
Crossref
Takafumi Tsushima, Nobue Sato, Yong-Mei Guo, Satoshi Uchiyama, Hirotaka Nakamura, Akihito Nagata, Chi Song-Gi, Nobuhiko Yamauchi, Yosuke Minami & Junichiro Yuda. (2022) Combination therapy with low doses of ponatinib and steroids in elderly and frail patients with Philadelphia chromosome-positive acute lymphoblastic leukemia. Annals of Hematology 101:7, pages 1603-1605.
Crossref
Robin Foà & Sabina Chiaretti. (2022) Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia. New England Journal of Medicine 386:25, pages 2399-2411.
Crossref
Khalil Saleh, Alexis Fernandez & Florence Pasquier. (2022) Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in Adults. Cancers 14:7, pages 1805.
Crossref
Valentina Nardi, Steven L McAfee, Paola Dal Cin, Harrison K Tsai, Philip C Amrein, Gabriela S Hobbs, Andrew M Brunner, Rupa Narayan, Julia Foster, Amir T Fathi & Hanno Hock. (2022) Chemotherapy Resistance in B-ALL with Cryptic NUP214-ABL1 Is Amenable to Kinase Inhibition and Immunotherapy . The Oncologist 27:2, pages 82-86.
Crossref
Lucie Aubert, Arnaud Petit, Yves Bertrand, Anne‐France Ray‐Lunven, Marie Angoso, Claire Pluchart, Frédéric Millot, Paul Saultier, Nathalie Cheikh, Isabelle Pellier, Dominique Plantaz, Anne Sirvent, Sandrine Thouvenin‐Doublet, Julie Valduga, Geneviève Plat, Fanny Rialland, Catherine Henry, Maxime Esvan & Virginie Gandemer. (2021) Therapeutic approach and outcome of children with Philadelphia chromosome‐positive acute lymphoblastic leukemia at first relapse in the era of tyrosine kinase inhibitors: An SFCE retrospective study. Pediatric Blood & Cancer 69:2.
Crossref
Huafeng Wang, Chang Yang, Ting Shi, Yi Zhang, Jiejing Qian, Yungui Wang, Yongxian Hu, Liping Mao, Xiujin Ye, Fang Liu, Zhenfang Xi, Lihong Shou, Caiyun Fu, Hua Naranmandura, Jie Jin & Hong-Hu Zhu. (2022) Venetoclax-ponatinib for T315I/compound-mutated Ph+ acute lymphoblastic leukemia. Blood Cancer Journal 12:1.
Crossref
蕊 张. (2022) Case Study of Complex Karyotype Acute Lymphoblastic Leukemia in the Elderly. Advances in Clinical Medicine 12:08, pages 7221-7226.
Crossref
Jacques-Olivier Bay, Carole Bouleuc, Nelly Firmin, Virginie Gandemer, Nicolas Magne, Daniel Orbach, Nicolas Penel, Manuel Rodrigues, Antoine Thiery-Vuillemin, Marie Wislez, Gilles L’Allemain, Renaud Sabatier & Jacques Robert. (2022) L’année 2021 dans tous ses états : une synthèse digérée. Bulletin du Cancer 109:1, pages 8-19.
Crossref
Oliver G. Ottmann. 2022. Clinical Management of Acute Lymphoblastic Leukemia. Clinical Management of Acute Lymphoblastic Leukemia 185 207 .
Junichiro Yuda, Nobuhiko Yamauchi, Ayumi Kuzume, Yong-Mei Guo, Nobue Sato & Yosuke Minami. (2021) Molecular remission after combination therapy with blinatumomab and ponatinib with relapsed/refractory Philadelphia chromosome-positive acute lymphocytic leukemia: two case reports. Journal of Medical Case Reports 15:1.
Crossref
Wellington F. Silva, Alexandre Silverio, Bruno Kosa Lino Duarte, Thais Ferraz Aguiar, Rodrigo Miguel Bendlin, Ires Hamyra Bezerra Massaut, Katia Borgia Barbosa Pagnano, Elvira D.R.P. Velloso, Vanderson Rocha & Eduardo Magalhães Rego. (2021) Philadelphia-positive B-lymphoblastic leukemia in a middle-income country – A real-world multicenter cohort. Leukemia Research 110, pages 106666.
Crossref
Ryujiro Hara, Makoto Onizuka, Eri Kikkawa, Sawako Shiraiwa, Kaito Harada, Yasuyuki Aoyama, Daisuke Ogiya, Masako Toyosaki, Rikio Suzuki, Sinichiro Machida, Ken Ohmachi, Yoshiaki Ogawa, Hiroshi Kawada, Hiromichi Matsushita & Kiyoshi Ando. (2021) Association between measurable residual disease kinetics and outcomes of Philadelphia chromosome-positive acute lymphoblastic leukemia. Annals of Hematology 100:10, pages 2479-2486.
Crossref
Patrick A. BrownBijal ShahAnjali AdvaniPatricia AounMichael W. BoyerPatrick W. BurkeDaniel J. DeAngeloShira DinnerAmir T. FathiJordan GauthierNitin JainSuzanne KirbyMichaela LiedtkeMark LitzowAaron LoganSelina LugerLori J. ManessStephanie MassaroRyan J. MattisonWilliam MayOlalekan OluwoleJae ParkAmanda PrzespolewskiSravanti RangarajuJeffrey E. RubnitzGeoffrey L. UyMadhuri VusirikalaMatthew Wieduwilt, Beth LynnRyan A. BerardiDeborah A. Freedman-CassMallory Campbell. (2021) Acute Lymphoblastic Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network 19:9, pages 1079-1109.
Crossref
. (2021) Blinatumomab/ponatinib. Reactions Weekly 1868:1, pages 119-119.
Crossref
Nitin Jain, Abhishek Maiti, Farhad Ravandi, Marina Konopleva, Naval Daver, Tapan Kadia, Naveen Pemmaraju, Nicholas Short, Partow Kebriaei, Jing Ning, Jorge Cortes, Elias Jabbour & Hagop Kantarjian. (2021) Inotuzumab ozogamicin with bosutinib for relapsed or refractory Philadelphia chromosome positive acute lymphoblastic leukemia or lymphoid blast phase of chronic myeloid leukemia. American Journal of Hematology 96:8, pages 1000-1007.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.